Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL

Precision Clinical Medicine

ISSN 2096-5303 · eISSN 2516-1571 · Oxford University Press · United Kingdom

Precision Clinical Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.7 (journal website); fully open access; APC about USD 2,000; median 55 days to acceptance (76 articles, last 24 months); 40 articles in 2025; indexed in ESCI and Scopus.

Impact factor8.7From the journal's website, 2025 value
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time55 daysMedian, submission to acceptance · 76 articles, last 24 months · PubMed
APCUSD 2,000Fully open access
Acceptance—No reports yet
Articles per year402025 · OpenAlex count

Scope

Aims, scope and focus

Precision Clinical Medicine is published by Oxford University Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Gut microbiota and health and SARS-CoV-2 and COVID-19 Research, together about 21.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Precision medicine, a new model of medicine that tailors healthcare to individual characteristics, is revolutionizing all areas of health and disease. These characteristics include genomic information as well as molecular, cellular, and image profiling and beyond, based on which individuals can be classified into subpopulations for specialized decision in the treatment and management of a disease. Precision medicine is one of the most exciting and promising frontiers in medicine, which holds the greatest potential in the discovery, development and application of precision prevention, diagnostics, therapeutics and prognostics. Such prospects necessitate concerted efforts from multi-disciplinary research and clinical experience in almost all fields of medicine to improve patient outcomes. Platforms are also required for the interaction of all involved knowledge to help healthcare professionals and researchers in the world exchange ideas, technologies, discoveries and experiences in applying precision medicine. Precision Clinical Medicine (PCM) commits itself to the combination of precision medical research and clinical application. PCM is a peer-reviewed, open access journal that publishes original research articles, case reports, reviews, editorials and perspectives on all aspects in the field of precision medicine in a timely manner. By doing so, the journal aims to provide new theories, methods, and evidence for disease diagnosis, treatment, prevention and prognosis, so as to establish a communication platform for clinicians and researchers that will impact practice of medicine. The journal covers all aspects of precision medicine, which uses novel means of diagnosis, treatment and prevention tailored to the needs of a patient or a sub-group of patients based on the specific genetic, phenotypic, or psychosocial characteristics. Clinical conditions include cancer, infectious disease, inherited diseases, complex diseases, rare diseases, etc. Topics include but not limited to the following: Genetics, cytogenetics, epigenetics Genomics, proteomics, and metabolomics, radiomics, pharmacogenomics, etc. Bioinformatics and computational biology Biomarker studies Molecular classification of diseases Medical imaging Novel technologies (eg. 3D printing, liquid biopsy, artificial intelligence for medicine, digital medicine) New applications of traditional technologies Regulatory, ethical and economic issues in precision medicine Abstracting and Indexing Precision Clin

From the journal's Aims & Scope

Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL

Editor-in-chief Weimin LiPublisher website

Editorial board by country: 35 in mainland China (about 44%); most named Mainland China 35, United States 29, United Kingdom 8, Canada 2, Australia 2 (80 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer Immunotherapy and BiomarkersMedicine8.3%
  2. Gut microbiota and healthBiochemistry, Genetics and Molecular Biology6.4%
  3. SARS-CoV-2 and COVID-19 ResearchMedicine6.4%
  4. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology6.4%
  5. COVID-19 Clinical Research StudiesMedicine6%
  6. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.3%
  7. Radiomics and Machine Learning in Medical ImagingMedicine5.3%
  8. Immune Cell Function and InteractionImmunology and Microbiology4.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorMedicine, Research & ExperimentalZone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorMedicine, Research & ExperimentalZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, Research & ExperimentalZone 4

Top journal: noReview journal: no

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PMCEmbasePublisher website

Other: EBSCO

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher) 2025
8.7Publisher website ·
5-year impact factor (publisher) 2025
5.5Publisher website ·
CiteScore 2026-06
8.7LetPub ·
CiteScore (publisher) 2025
8.7Publisher website ·
SJR 2026-06
1.66LetPub ·
SNIP 2026-06
1.25LetPub ·
h-index
37OpenAlex ·
i10-index
134OpenAlex ·
2-year mean citedness
6.17OpenAlex ·
Self-citation rate
7.8%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
29LetPub ·
Downloads per year (publisher) 2025
136,421Publisher website ·

Articles by year OpenAlex count · 283 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026292924
20254040237
20243434374
20233434407
20223030663
20213030808

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

55 daysMedian, submission to acceptance · P25–P75 34 days – 80 days

Acceptance to online
median 3 days (76 articles)
Submission to online
median 65 days
Sample
76 articles with submission and acceptance dates (80 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 5 weeksLetPub ·
Submission to publication (journal-reported)
about 5 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 2,000NoCC BY, CC BY-NC
OpenAlexUSD 2,000——
LetPubNo APCNo—
Publisher websiteUSD 3,625——

Other charges and waivers (author guidelines)

Discounts
20
Submission fee
USD 3,625

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare1 items from the author guidelines
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted7
  1. case reportManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  2. commentaryManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  3. opinionManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  4. original researchManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  5. research articleManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  6. reviewManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
  7. review articleManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…Length not stated
Publisher website
Policy excerpts from the journal's websiteConflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints
Conflicts of interest Conflict of interest

Oxford University Press requires declaration of any conflict of interest upon submission online. If the manuscript is published, conflict of interest information will be communicated in a statement in the published paper.

Source ↗Publisher website ·
Data availability Availability of Data and Materials

Where ethically feasible, Precision Clinical Medicine strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. For information on general repositories for all data types, and a list of …

Source ↗Publisher website ·
License & copyright Third-party copyright

In order to reproduce any third party material, including tables, figures, or images, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. When seeking to reproduce any kind of third party material authors should request the following: non-exclusive rights to reproduce the material in t…

Source ↗Publisher website ·
Open access Third-party content in Open Access papers

If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material: Title of content. Author, Original publication, year of original publication, by permission of [rights holder]. This image/content is not covered by the terms of …

Source ↗Publisher website ·
Peer review Peer Review

This journal operates single-anonymised peer review, meaning that the Authors identity is known to the Editor and to the Reviewers, but that the Reviewers’ identities are known only to the Editor and are hidden from the Authors. For full details about the peer review process, see Fair editing and peer review. All submissions to the journal are initially reviewed by one of the Editors. At this stag…

Source ↗Publisher website ·
Plagiarism Plagiarism

Manuscripts submitted to Precision Clinical Medicine may be screened with iThenticate anti-plagiarism software in an attempt to detect and prevent plagiarism. Any manuscript may be screened, especially if there is reason to suppose part or all of the text has been previously published. Prior to final acceptance any manuscript that has not already been screened may be put through iThenticate. More …

Source ↗Publisher website ·
Preprints Preprint policy

Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiv…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Oxford University Press
Country or region
United Kingdom
Language
English
ISSN
2096-5303
Electronic ISSN
2516-1571
Latest issue on the website
Volume 9, Issue 3 (September 2026)
Official links

FAQ

Frequently asked questions about Precision Clinical Medicine

What CAS zone is Precision Clinical Medicine in?

In the 2025 upgraded edition of the CAS Journal Ranking, Precision Clinical Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Precision Clinical Medicine?

The journal's website gives an impact factor of 8.7 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 8.7, h-index 37.

How long does peer review take at Precision Clinical Medicine?

Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 34–80 days); authors report an average review time of about 5 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Precision Clinical Medicine based?

Of the 80 board members whose country the journal's board page names, 35 (about 44%) are in mainland China; the countries named most often are Mainland China (35), United States (29) and United Kingdom (8). Counted from the institutions listed on the board page; for reference only.

Which databases index Precision Clinical Medicine?

According to LetPub and DOAJ records, Precision Clinical Medicine is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC and Embase; that list has not been checked against each database.

Is Precision Clinical Medicine open access, and what is the APC?

Precision Clinical Medicine is a fully open-access journal. APC about USD 2,000.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .